← All trials
NCT01308294
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2010
- Primary completion
- Apr 1, 2014
- Completion date
- Apr 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 16
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of LausanneLead sponsor
- Immutep S.A.Collaborator
- University of LausanneReponsible party - principal investigator
- University of LausanneOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.